Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

March 20, 2025

Porton Advanced and Eureka to expedite T-cell therapy development

Contract development and manufacturing organisation (CDMO) Porton Advanced has announced a partnership with Eureka Therapeutics to expedite the worldwide clinical development of T-cell therapies.

Porton Advanced and Eureka to expedite T-cell therapy development